ESC 365 - Doctor Yoriyasu Suzuki

Speaker illustration

Doctor Yoriyasu Suzuki

Aichi Medical University, Nagakute-cho (Japan)

Efficacy of tolvaptan in treating patients with heart failure with the preserved ejection fraction

Event: Acute Cardiovascular Care 2019

Topic: Pharmacotherapy

Session: Acute Heart Failure: Pharmacotherapy

Efficacy of Tolvaptan for the first hospitalized patients with acute decompensated heart failure

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Acute Heart Failure– Treatment

Prevalence and clinical impact of tissue protrusion after stent implantation for acute coronary syndrome

Event: ESC Congress 2017

Topic: PCI: primary PCI / patient subsets

Session: Primary and acute PCI

The difference of benefit of tolvaptan for acute decompensated heart failure within different etiologies

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute heart failure (therapy)

Session: Acute heart failure

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources